genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2018
Celldex Therapeutics
Featured
Antibodies and Antibody-Drug Conjugate Higher Order Structures Revealed
Industry News
Celldex Glioblastoma Candidate Rintega Fails Phase III Trial
News
BMS, Celldex Collaborate on Trial for Cancer Combo
Cancer
CellDex to Use MDxHealth’s Assay in Phase III Brain Cancer Study
Drug Discovery
CellDex to Buy CuraGen in Deal Valued at $94.5M
Drug Discovery
Celldex Licenses Cholera and ETEC Vaccine Programs to Vaccine Technologies
News
Celldex Enters Licensing Deal to Develop CD27 mAbs for Cancer
News
Rotarix Launch Results in $10M Payment to Celldex
News
Avant Stock Spikes after Merger Agreement with Celldex
Scroll Up
Scroll Up
